CYC Share Price Performance
AU$0
-1.65 (-100.00%)
Price AU$0
Fair ValueAU$1.49
Share Pricen/a
Benign Growth For Cyclopharm Limited (ASX:CYC) Underpins Stock's 29% Plummet
Oct 13
Cyclopharm Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 19 Fair Values set on narratives written by author
CYC Community Narratives
AN
Fair Value AU$1.49 34.3% undervalued intrinsic discount
US Healthcare Trends Will Accelerate Advanced Technegas Integration
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
US Healthcare Trends Will Accelerate Advanced Technegas Integration
Key Takeaways U.S. market traction, rising respiratory disease demand, and updated guidelines position the company for strong recurring revenue and margin expansion via Technegas adoption. Operational leverage from earlier investments and expanding Technegas indications drive volume growth, improved earnings, and higher annuity-like income streams.Read more
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
AN
AU$1.49
34.3% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue
38.17% p.a.
Profit Margin
9.14%
Future PE
27.53x
Price in 2028
AU$1.83
Trending Discussion
Recently Updated Narratives
AN
US Healthcare Trends Will Accelerate Advanced Technegas Integration
Fair Value: AU$1.49 34.3% undervalued intrinsic discount
9 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Cyclopharm Limited Key Details
About CYC
- Founded
- 1986
- Employees
- 97
- CEO
- WebsiteView website
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.
Recent CYC News & Updates
